Wealthcare Advisory Partners’s Avantis Emerging Markets ex-China Equity ETF AVXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Sell
128,604
-5,350
-4% -$426K 0.21% 96
2026
Q1
$9.06M Buy
133,954
+25,309
+23% +$1.76M 0.18% 120
2025
Q4
$6.93M Buy
108,645
+12,437
+13% +$773K 0.14% 138
2025
Q3
$5.77M Buy
96,208
+24,770
+35% +$1.43M 0.12% 147
2025
Q2
$4.04M Sell
71,438
-318
-0.4% -$16.5K 0.09% 181
2025
Q1
$3.49M Buy
+71,756
New +$3.56M 0.09% 186

Other funds holding AVXC

Wealthcare Advisory Partners's AVXC Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its Avantis Emerging Markets ex-China Equity ETF (AVXC) stake by 4% in Q2 2026, selling an estimated $426K and leaving 128,604 shares worth $11M. The position accounts for 0.21% of the portfolio, ranked #96.

Wealthcare Advisory Partners first reported a position in AVXC in Q1 2025 and has held it in 6 quarters since. 12 funds tracked by Wall St. Rank hold AVXC as of Q2 2026.

  • Wealthcare Advisory Partners held 128,604 shares of Avantis Emerging Markets ex-China Equity ETF worth $11M as of Q2 2026.
  • Wealthcare Advisory Partners sold 5,350 Avantis Emerging Markets ex-China Equity ETF shares in Q2 2026, an estimated $426K.
  • Avantis Emerging Markets ex-China Equity ETF made up 0.21% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #96 holding.
  • Wealthcare Advisory Partners first reported a position in Avantis Emerging Markets ex-China Equity ETF in Q1 2025 and has held it in 6 quarters since.
  • 12 funds tracked by Wall St. Rank held Avantis Emerging Markets ex-China Equity ETF as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.